Biofilms are highly resistant communities of bacteria that pose a major challenge in the treatment of infections. While studying biofilm formation in laboratory conditions has been extensively conducted, understanding their ...
Cell & Microbiology
Aug 1, 2023
0
46
All hospitals battle an invisible threat: Pseudomonas aeruginosa. It is a type of bacteria that affects thousands of patients each year in intensive care units, where it can cause sepsis, pneumonia and other types of infections.
Cell & Microbiology
Jul 12, 2023
0
0
Infections are among the most frequent complications during a hospital stay. Researchers at the University of Basel have now uncovered why one of the most dangerous nosocomial pathogens is so difficult to combat. It follows ...
Cell & Microbiology
Jun 20, 2023
0
38
People with weakened immune systems are at constant risk of infection. Pseudomonas aeruginosa, a common environmental bacterium, can colonize different body parts, such as the lungs, leading to persistent, chronic infections ...
Cell & Microbiology
Jun 14, 2023
0
73
Similar to how cells within human tissues communicate and function together as a whole, bacteria are also able to communicate with each other through chemical signals, a behavior known as quorum signaling (QS). These chemical ...
Biochemistry
Apr 4, 2023
0
33
EPFL scientists are developing a new approach that can help stem the tide of antibiotic resistance. "Antibiotic-resistant infections are responsible for over one million deaths every year, including 250,000 children under ...
Cell & Microbiology
Mar 30, 2023
0
2
Researchers from Freiburg and Strasbourg have discovered a strong immunological effect of the molecule LecB—and a way to prevent it.
Cell & Microbiology
Mar 1, 2023
0
34
The pathogen Pseudomonas aeruginosa is the cause of a large number of serious infections and places a particular burden on immunocompromised patients. The increasing spread of antimicrobial resistance makes it even more difficult ...
Biochemistry
Jan 23, 2023
0
35
Researchers have designed the first "living medicine" to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria that is naturally resistant to many types of antibiotics and is a common source ...
Cell & Microbiology
Jan 19, 2023
1
75
The hospital pathogen Pseudomonas aeruginosa requires the sugar-binding proteins LecA and LecB to form biofilms as well as to attach to and penetrate host cells. These so-called lectins are therefore suitable targets for ...
Biochemistry
Jan 16, 2023
0
37
